{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T22:36:50Z","timestamp":1785883010636,"version":"3.56.0"},"reference-count":38,"publisher":"MDPI AG","issue":"1","license":[{"start":{"date-parts":[[2023,1,4]],"date-time":"2023-01-04T00:00:00Z","timestamp":1672790400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Life"],"abstract":"<jats:p>Osteoarthritis (OA) is a whole-joint disease that affects cartilage, bone, and synovium as well as ligaments, menisci, and muscles [...]<\/jats:p>","DOI":"10.3390\/life13010140","type":"journal-article","created":{"date-parts":[[2023,1,4]],"date-time":"2023-01-04T05:02:30Z","timestamp":1672808550000},"page":"140","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Knee Osteoarthritis\u2014How Close Are We to Disease-Modifying Treatment: Emphasis on Metabolic Type Knee Osteoarthritis"],"prefix":"10.3390","volume":"13","author":[{"given":"Sevdalina Nikolova","family":"Lambova","sequence":"first","affiliation":[{"name":"Department of Propaedeutics of Internal Diseases, Faculty of Medicine, Medical University of Plovdiv, 4002 Plovdiv, Bulgaria"},{"name":"Department in Rheumatology, MHAT \u201cSveti Mina\u201d, 4002 Plovdiv, Bulgaria"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2023,1,4]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"87","DOI":"10.3109\/03009742.2015.1060259","article-title":"Inflammation (or synovitis) -driven osteoarthritis: An opportunity for personalizing prognosis and treatment?","volume":"45","author":"Siebuhr","year":"2016","journal-title":"Scand. J. Rheumatol."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.1136\/ard.2003.011742","article-title":"EULAR Recommendations 2003: An evidence based approach to the management of knee osteoarthritis: Report of a Task Force of the Standing Committee for International Clinical Studies Including Therapeutic Trials (ESCISIT)","volume":"62","author":"Jordan","year":"2003","journal-title":"Ann. Rheum. Dis."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1177\/0363546514533777","article-title":"Chondroprotection and the prevention of osteoarthritis progression of the knee: A systematic review of treatment agents","volume":"43","author":"Gallagher","year":"2015","journal-title":"Am. Sports Med."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"2921","DOI":"10.2147\/DDDT.S295224","article-title":"The development of disease-modifying therapies for osteoarthritis (DMOADs): The evidence to date","volume":"15","author":"Oo","year":"2021","journal-title":"Drug Des. Dev. Ther."},{"key":"ref_5","doi-asserted-by":"crossref","unstructured":"Dell\u2019Isola, A., Allan, R., Smith, S.L., Marreiros, S.S.P., and Steultjens, M. (2016). Identification of clinical phenotypes in knee osteoarthritis: A systematic review of the literature. BMC Musculoskelet. Disord., 17.","DOI":"10.1186\/s12891-016-1286-2"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"1926","DOI":"10.1016\/j.joca.2017.08.009","article-title":"Knee osteoarthritis phenotypes and their relevance for outcomes: A systematic review","volume":"25","author":"Deveza","year":"2017","journal-title":"Osteoarthr. Cartil."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1016\/j.joca.2006.09.007","article-title":"Clusters of biochemical markers are associated with radiographic subtypes of osteoarthritis (OA) in subject with familial OA at multiple sites. The GARP study","volume":"15","author":"Meulenbelt","year":"2007","journal-title":"Osteoarthr. Cartil."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"1915","DOI":"10.1016\/j.joca.2015.08.006","article-title":"Plasma levels of interleukin-1 receptor antagonist (IL1Ra) predict radiographic progression of symptomatic knee osteoarthritis","volume":"23","author":"Attur","year":"2015","journal-title":"Osteoarthr. Cartil."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"1816","DOI":"10.1136\/ard.2009.124420","article-title":"Relationship of serum markers of cartilage metabolism to imaging and clinical outcome measures of knee joint structure","volume":"69","author":"Berry","year":"2010","journal-title":"Ann. Rheum. Dis."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"1252","DOI":"10.3899\/jrheum.091055","article-title":"Markers of bone formation and resorption identify subgroups of patients with clinical knee osteoarthritis who have reduced rates of cartilage loss","volume":"37","author":"Berry","year":"2010","journal-title":"J. Rheumatol."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"100052","DOI":"10.1016\/j.medntd.2020.100052","article-title":"Metabolic syndrome and osteoarthritis: Possible mechanisms and management strategies","volume":"9","author":"Tan","year":"2021","journal-title":"Med. Nov. Technol. Devices"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"7242478","DOI":"10.1155\/2016\/7242478","article-title":"Metabolic syndrome increases the risk for knee osteoarthritis: A meta-analysis","volume":"2016","author":"Wang","year":"2016","journal-title":"Evid.-Based Complement. Altern. Med."},{"key":"ref_13","doi-asserted-by":"crossref","unstructured":"Lambova, S.N., Batsalova, T., Moten, D., Stoyanova, S., Georgieva, E., Belenska-Todorova, L., Kolchakova, D., and Dzhambazov, B. (2021). Serum leptin and resistin levels in knee osteoarthritis\u2014Clinical and radiologic links: Towards precise definition of metabolic type knee osteoarthritis. Biomedicines, 9.","DOI":"10.3390\/biomedicines9081019"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"88","DOI":"10.18231\/j.ijos.2019.015","article-title":"Incidence of primary osteoarthritis knee below 40 years of age and its etiological factors: OPD survey of 200 knee pain patients","volume":"5","author":"Khanna","year":"2019","journal-title":"Indian J. Orthop. Surg."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1016\/j.joca.2015.12.006","article-title":"Differences in MRI features between two different osteoarthritis subpopulations: Data from the Osteoarthritis Initiative","volume":"24","author":"Roze","year":"2016","journal-title":"Osteoarthr. Cartil."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1016\/j.joca.2021.02.004","article-title":"A Phase 2b randomized trial of lorecivivint, a novel intra-articular CLK2 \/ DYRK1A inhibitor and Wnt pathway modulator for knee osteoarthritis","volume":"29","author":"Yazici","year":"2021","journal-title":"Osteoarthr. Cartil."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/j.joca.2011.12.004","article-title":"Molecular differentiation between osteophytic and articular cartilage e clues for a transient and permanent chondrocyte phenotype","volume":"20","author":"Gelse","year":"2012","journal-title":"Osteoarthr. Cartil."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"1360","DOI":"10.1001\/jama.2019.14735","article-title":"Effect of Intra-Articular Sprifermin vs Placebo on Femorotibial Joint Cartilage Thickness in Patients With Osteoarthritis The FORWARD Randomized Clinical Trial","volume":"322","author":"Hochberg","year":"2019","journal-title":"JAMA"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1186\/ar4405","article-title":"Subchondral bone in osteoarthritis: Insight into risk factors and microstructural changes","volume":"15","author":"Li","year":"2013","journal-title":"Arthritis Res. Ther."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1097\/BOR.0000000000000181","article-title":"Subchondral bone and osteoarthritis","volume":"27","year":"2015","journal-title":"Curr. Opin. Rheumatol."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/j.joca.2017.11.013","article-title":"Are bisphosphonates efficacious in knee osteoarthritis? A meta-analysis of randomized controlled trials","volume":"26","author":"Vaysbrot","year":"2018","journal-title":"Osteoarthr. Cartil."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"1322","DOI":"10.1136\/annrheumdis-2011-200970","article-title":"Zoledronic acid reduces knee pain and bone marrow lesions over 1 year: A randomised controlled trial","volume":"71","author":"Laslett","year":"2012","journal-title":"Ann. Rheum. Dis."},{"key":"ref_23","first-page":"60","article-title":"Bisphosphonates as disease-modifying drugs in osteoarthritis preclinical studies: A systematic review from 2000 to 2020","volume":"6","author":"Permuy","year":"2021","journal-title":"Arthritis Res. Ther."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1186\/s13075-017-1229-9","article-title":"Synovitis in osteoarthritis: Current understanding with therapeutic implications","volume":"19","author":"Mathiessen","year":"2017","journal-title":"Arthritis Res. Ther."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"1830","DOI":"10.1093\/rheumatology\/key131","article-title":"Conventional and biologic disease-modifying anti-rheumatic drugs for osteoarthritis: A meta-analysis of randomized controlled trials","volume":"57","author":"Persson","year":"2018","journal-title":"Rheumatology"},{"key":"ref_26","doi-asserted-by":"crossref","unstructured":"Li, Y., Mai, Y., Cao, P., Wen, X., Fan, T., Wang, X., Ruan, G., Tang, S.A., Ding, C., and Zhu, Z. (2022). Relative efficacy and safety of anti-inflammatory biologic agents for osteoarthritis: A conventional and network meta-analysis. J. Clin. Med., 11.","DOI":"10.3390\/jcm11143958"},{"key":"ref_27","doi-asserted-by":"crossref","unstructured":"Nurul, A.A., Azlan, M., Ahmad Mohd Zain, M.R., Sebastian, A.A., Fan, Y.Z., and Fauzi, M.B. (2021). Mesenchymal stem cells: Current concepts in the management of inflammation in osteoarthritis. Biomedicines, 9.","DOI":"10.3390\/biomedicines9070785"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"81","DOI":"10.2174\/157488810790442796","article-title":"Safety and Complications Reporting on the Re-implantation of Culture-Expanded Mesenchymal Stem Cells using Autologous Platelet Lysate Technique","volume":"5","author":"Centeno","year":"2010","journal-title":"Curr. Stem Cell Res. Ther."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1186\/s13075-016-1195-7","article-title":"Efficacy and safety of adult human bone marrow-derived, cultured, pooled, allogeneic mesenchymal stromal cells (Stempeucel\u00ae): Preclinical and clinical trial in osteoarthritis of the knee joint","volume":"18","author":"Gupta","year":"2016","journal-title":"Arthritis Res. Ther."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"3499","DOI":"10.1007\/s00167-018-4955-x","article-title":"Limited evidence for adipose-derived stem cell therapy on the treatment of osteoarthritis","volume":"26","author":"Hurley","year":"2018","journal-title":"Knee Surg. Sport Traumatol. Arthrosc."},{"key":"ref_31","doi-asserted-by":"crossref","unstructured":"Timmons, R.B., Sugaya, K., and Bane, L.D. (2022). Homologous Use of Allogeneic Umbilical Cord Tissue to Reduce Knee Pain and Improve Knee Function. Life, 12.","DOI":"10.3390\/life12020260"},{"key":"ref_32","doi-asserted-by":"crossref","unstructured":"Belenska-Todorova, L., Lambova, S.N., Stoyanova, S., Georgieva, E., Batsalova, T., Moten, D., Kolchakova, D., and Dzhambazov, B. (2021). Disease-modifying potential of metformin and alendronate in an experimental mouse model of osteoarthritis. Biomedicines, 9.","DOI":"10.3390\/biomedicines9081017"},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1186\/s13075-019-1915-x","article-title":"Association between metformin use and disease progression in obese people with knee osteoarthritis: Data from the Osteoarthritis Initiative\u2014A prospective cohort study","volume":"21","author":"Wang","year":"2019","journal-title":"Arthritis Res. Ther."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"2009","DOI":"10.1111\/jch.14362","article-title":"The effects of different antihypertensive drugs on pain and joint space width of knee osteoarthritis\u2014A comparative study with data from Osteoarthritis Initiative","volume":"23","author":"Li","year":"2021","journal-title":"J. Clin. Hypertens."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"1321","DOI":"10.1016\/j.jpain.2015.09.004","article-title":"Differences in the Antinociceptive Effects and Binding Properties of Propranolol and Bupranolol Enantiomers","volume":"16","author":"Martin","year":"2015","journal-title":"J. Pain"},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"1076","DOI":"10.1002\/acr.23091","article-title":"Association of beta-blocker use with less prevalent joint pain and lower opioid requirement in people with osteoarthritis","volume":"69","author":"Valdes","year":"2017","journal-title":"Arthritis Care Res."},{"key":"ref_37","first-page":"12584","article-title":"Captopril, an angiotensin-converting enzyme inhibitor, possesses chondroprotective efficacy in a rat model of osteoarthritis through suppression local renin-angiotensin system","volume":"8","author":"Tang","year":"2015","journal-title":"Int. J. Clin. Exp. Med."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1136\/annrheumdis-2016-eular.2888","article-title":"Does renin-angiotensin-aldosterone system blockade influence pain, function and radiographic progression in knee osteoarthritis? An analysis of Osteoarthritis Initiative data","volume":"75","author":"Shirinsky","year":"2016","journal-title":"Ann. Rheum. Dis."}],"container-title":["Life"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2075-1729\/13\/1\/140\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T17:58:34Z","timestamp":1760119114000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2075-1729\/13\/1\/140"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,1,4]]},"references-count":38,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,1]]}},"alternative-id":["life13010140"],"URL":"https:\/\/doi.org\/10.3390\/life13010140","relation":{},"ISSN":["2075-1729"],"issn-type":[{"value":"2075-1729","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,1,4]]}}}